INSULIN Act of 2026

The power to regulate commerce among the several states is expressly vested in Congress by Article I, Section 8, Clause 3. So long as the INSULIN Act of 2026 operates directly upon the interstate sale, distribution, or pricing of insulin—a good that moves in interstate commerce—it falls within the legitimate scope of that authority. The Necessary and Proper Clause (Article I, Section 8, Clause 18) further empowers Congress to enact all laws which shall be necessary and proper for carrying into execution the foregoing powers. However, if the Act attempts to command the States to regulate intras…

This bill, by directing the federal hand to regulate the price of insulin, exceeds the enumerated powers delegated to Congress. The Constitution grants no authority to fix the price of medicines, which is a matter of police power reserved to the states and the people. The general welfare clause is not a blank check for any measure Congress deems beneficial; it is limited to the enumerated objects of federal power. To permit such legislation would be to sanction an unbounded construction of federal authority, eroding the very foundations of our compact. The Tenth Amendment stands as a bulwark a…

The INSULIN Act of 2026, as a federal regulation of insulin pricing and access, may be constitutional only if it falls within the enumerated powers of Congress, particularly the power to regulate interstate commerce. Insulin is a commodity that moves in interstate commerce, and Congress may legitimately address price distortions that burden such commerce. However, the Constitution reserves to the states all powers not delegated to the United States (Tenth Amendment). If the Act extends to purely intrastate transactions or imposes price controls without a clear connection to an interstate comme…

The INSULIN Act of 2026 is a constitutional exercise of the power of Congress to regulate commerce among the several states. Under the Commerce Clause, Congress may regulate all commercial intercourse that concerns more than one state, and the pricing of insulin—a drug widely distributed and sold in interstate markets—falls squarely within that authority. The means chosen by Congress, whether by direct price controls or other mechanisms, are appropriate and plainly adapted to the legitimate end of regulating interstate commerce in pharmaceuticals, as affirmed by the doctrine of implied powers.…